Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Change in Cash (2020 - 2025)

Bio Essence has reported Change in Cash over the past 6 years, most recently at -$28741.0 for Q4 2025.

  • For Q4 2025, Change in Cash fell 0.63% year-over-year to -$28741.0; the TTM value through Dec 2025 reached -$1371.0, down 209.07%, while the annual FY2025 figure was -$1371.0, 209.07% down from the prior year.
  • Change in Cash for Q4 2025 was -$28741.0 at Bio Essence, down from $28741.0 in the prior quarter.
  • Over five years, Change in Cash peaked at $28741.0 in Q3 2025 and troughed at -$28741.0 in Q4 2025.
  • A 5-year average of -$280.26 and a median of $23.0 in 2024 define the central range for Change in Cash.
  • On a YoY basis, Change in Cash climbed as much as 4597.57% in 2024 and fell as far as 114344.0% in 2024.
  • Year by year, Change in Cash stood at -$26410.0 in 2021, then soared by 121.54% to $5690.0 in 2022, then tumbled by 99.56% to $25.0 in 2023, then tumbled by 114344.0% to -$28561.0 in 2024, then fell by 0.63% to -$28741.0 in 2025.
  • Business Quant data shows Change in Cash for BIOE at -$28741.0 in Q4 2025, $28741.0 in Q3 2025, and -$1371.0 in Q1 2025.